Interventions for preventing silent cerebral infarcts in people
with sickle cell disease (Protocol)

Interventions for preventing silent cerebral infarcts in people with sickle cell disease (Protocol)

This is the protocol for a review and there is no abstract. The objectives are as follows:<br/><br/> To assess the effectiveness of red blood transfusions and hydroxyurea alone or in combination and HSCT to reduce or prevent SCI in people with SCD.

Dettagli Bibliografici
Autori principali:	Estcourt, L, Fortin, P, Hopewell, S, Trivella, M, Doree, C, Abboud, M
Natura:	Journal article
Pubblicazione:	John Wiley & Sons, Ltd 2016

Documenti analoghi

Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
di: Estcourt, L, et al.
Pubblicazione: (2017)

Interventions for preventing silent cerebral infarcts in people with sickle cell disease
di: Estcourt, LJ, et al.
Pubblicazione: (2020)

Interventions for chronic kidney disease in people with sickle cell disease (Protocol)
di: Roy, N, et al.
Pubblicazione: (2016)

Interventions for chronic kidney disease in people with sickle cell disease
di: Roy, N, et al.
Pubblicazione: (2017)

Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
di: Fortin, P, et al.
Pubblicazione: (2016)

Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
di: Fortin, P, et al.
Pubblicazione: (2018)

Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
di: Estcourt, L, et al.
Pubblicazione: (2017)

Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews (Protocol)
di: Estcourt, L, et al.
Pubblicazione: (2016)

Preoperative blood transfusions for sickle cell disease
di: Estcourt, L, et al.
Pubblicazione: (2016)

Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia (Protocol)
di: Estcourt, L, et al.
Pubblicazione: (2015)

Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation (Protocol)
di: Estcourt, L, et al.
Pubblicazione: (2017)

Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction
di: Estcourt, L, et al.
Pubblicazione: (2015)

Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
di: Geneen, LJ, et al.
Pubblicazione: (2023)

Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews
di: Fortin, P, et al.
Pubblicazione: (2018)

Interventions for chronic kidney disease in people with sickle cell disease.
di: Roy, NB, et al.
Pubblicazione: (2023)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
di: Estcourt, L, et al.
Pubblicazione: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
di: Estcourt, L, et al.
Pubblicazione: (2015)

Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease (Review)
di: Estcourt, L, et al.
Pubblicazione: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
di: Estcourt, L, et al.
Pubblicazione: (2015)

Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction
di: Estcourt, L, et al.
Pubblicazione: (2016)

Plasma transfusions prior to insertion of central lines for people with abnormal coagulation
di: Hall, D, et al.
Pubblicazione: (2016)

Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia (Protocol)
di: Estcourt, L, et al.
Pubblicazione: (2015)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
di: Estcourt, L, et al.
Pubblicazione: (2017)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
di: Estcourt, L, et al.
Pubblicazione: (2018)

Silent Infarcts with Sickle Cell Anemia
di: J Gordon Millichap
Pubblicazione: (2002-01-01)

Plasma transfusions prior to insertion of central lines for patients with abnormal coagulation (Protocol)
di: Hall, DP, et al.
Pubblicazione: (2015)

Pathogen-reduced platelets for the prevention of bleeding (Review)
di: Estcourt, L, et al.
Pubblicazione: (2017)

Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia
di: Estcourt, L, et al.
Pubblicazione: (2016)

Quantification of Silent Cerebral Infarction on High-Resolution FLAIR and Cognition in Sickle Cell Anemia
di: Hanne Stotesbury, et al.
Pubblicazione: (2022-06-01)

Pathogen-reduced platelets for the prevention of bleeding.
di: Butler, C, et al.
Pubblicazione: (2013)

Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis
di: Maite E. Houwing, et al.
Pubblicazione: (2020-12-01)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
di: Desborough, M, et al.
Pubblicazione: (2016)

Pathogen-reduced platelets for the prevention of bleeding (Review)
di: Butler, C, et al.
Pubblicazione: (2013)

Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction
di: Sanjay Tewari, et al.
Pubblicazione: (2018-07-01)

Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease
di: Estcourt, L, et al.
Pubblicazione: (2019)

Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders (Protocol)
di: Gu, Y, et al.
Pubblicazione: (2015)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
di: Butler, C, et al.
Pubblicazione: (2011)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
di: Estcourt, L, et al.
Pubblicazione: (2014)

Quantitative susceptibility mapping (QSM) and R2* of silent cerebral infarcts in sickle cell anemia
di: Russell Murdoch, et al.
Pubblicazione: (2022-10-01)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
di: Estcourt, L, et al.
Pubblicazione: (2016)